Related Experiment Video

Updated: Aug 7, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Live viral vaccines in a DiGeorge syndrome patient

V Waters1, K S Peterson, P LaRussa

  • 1Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, University of Toronto, Toronto, Canada. Valerie.waters@sickkids.ca

Archives of Disease in Childhood
|June 27, 2006
PubMed

Insights

A child with DiGeorge syndrome died from pneumonia after receiving live viral vaccines. Live viral vaccines are not recommended for children with severe immunodeficiency due to insufficient safety data.

Area of Science:

  • Immunology
  • Pediatrics
  • Virology

Background:

  • DiGeorge syndrome is a genetic disorder affecting immune system development.
  • Pneumonia is a common and serious infection in young children.
  • Live viral vaccines are typically recommended for infants and children.

Observation:

  • A 13-month-old male with partial DiGeorge syndrome developed pneumonia.
  • The child received live viral vaccines.
  • The child subsequently died.

Findings:

  • The case highlights a potential risk of live viral vaccines in children with DiGeorge syndrome.
  • While some children with DiGeorge syndrome tolerate live viral vaccines, severe immunodeficiency poses a risk.
  • There is a lack of comprehensive data on the safety of live viral vaccines in this population.

Implications:

  • Clinicians should exercise caution when administering live viral vaccines to children with DiGeorge syndrome, especially those with severe immunodeficiency.
  • Further research is needed to establish clear guidelines for vaccination in children with DiGeorge syndrome.
  • This case underscores the importance of considering individual immune status before vaccination.

More Related Videos

Viral Tracing of Genetically Defined Neural Circuitry13:06

Viral Tracing of Genetically Defined Neural Circuitry

Published on: October 17, 2012

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy09:13

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

Related Concept Videos

Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...